Agios Pharma Shares Rally After FDA Expands Approval for Breakthrough Blood Disorder Drug
FDA expansion strengthens Agios growth outlook and advances treatment options globally. Agios Pharmaceuticals saw a sharp rise in its share
Read More
Factual Version of a Story
FDA regulatory update